New approaches for imaging tumour responses to treatment

K Brindle - Nature Reviews Cancer, 2008 - nature.com
Tumour responses to treatment are still largely assessed from imaging measurements of
reductions in tumour size. However, this can take several weeks to become manifest and in …

Tumor cell metabolism imaging

C Plathow, WA Weber - Journal of Nuclear Medicine, 2008 - Soc Nuclear Med
Molecular imaging of tumor metabolism has gained considerable interest, since preclinical
studies have indicated a close relationship between the activation of various oncogenes and …

Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer

D Groheux, S Giacchetti, JL Moretti, R Porcher… - European journal of …, 2011 - Springer
Purpose The aim of this study was to determine the impact of the main clinicopathological
and biological prognostic factors of breast cancer on 18 F-fluorodeoxyglucose (FDG) uptake …

18F-FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterization

H Jadvar, A Alavi, SS Gambhir - Journal of Nuclear Medicine, 2009 - Soc Nuclear Med
It is hoped that in the not too distant future, noninvasive imaging–based molecular
interrogation and characterization of tumors can improve our fundamental understanding of …

Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F …

S Ueda, H Tsuda, H Asakawa… - Japanese journal of …, 2008 - academic.oup.com
Objective Using integrated 18F-fluorodeoxyglucose positron emission
tomography/computed tomography fusion imaging (18F-FDG PET/CT), the clinical …

[HTML][HTML] Inhibition of glycolytic enzymes mediated by pharmacologically activated p53: targeting Warburg effect to fight cancer

J Zawacka-Pankau, VV Grinkevich, S Hünten… - Journal of Biological …, 2011 - ASBMB
Unique sensitivity of tumor cells to the inhibition of glycolysis is a good target for anticancer
therapy. Here, we demonstrate that the pharmacologically activated tumor suppressor p53 …

Glucose avidity of carcinomas

ÁD Ortega, M Sánchez-Aragó, D Giner-Sánchez… - Cancer letters, 2009 - Elsevier
The cancer cell phenotype has been summarized in six hallmarks [D. Hanahan, RA
Weinberg, The hallmarks of cancer, Cell 100 (1)(2000) 57–70]. Following the conceptual …

[HTML][HTML] Utility of 18F FDG-PET/CT for predicting prognosis of luminal-type breast cancer

K Aogi, T Kadoya, Y Sugawara, S Kiyoto… - Breast cancer research …, 2015 - Springer
Postoperative prognosis is better for hormonal receptor-positive breast cancer than for other
phenotypes; however, there are no definitive predictive factors for relapse or survival. This …

[HTML][HTML] The tumor suppressor function of mitochondria: translation into the clinics

JM Cuezva, ÁD Ortega, I Willers… - … et Biophysica Acta (BBA …, 2009 - Elsevier
Recently, the inevitable metabolic reprogramming experienced by cancer cells as a result of
the onset of cellular proliferation has been added to the list of hallmarks of the cancer cell …

Cellular life span and the Warburg effect

H Kondoh - Experimental cell research, 2008 - Elsevier
Enhanced glycolysis is observed in most of cancerous cells and tissues, called as the
Warburg effect. Recent advance in senescent biology implicates that the metabolic shift to …